Dynavax Technologies Corporation Financials

Market Capitalization $1.23 Billion as of July 1, 2025

Valuations Metrics as of Jul. 5, 2025

Trailing PE	54.60
Forward PE	28.53
Price to Sales TTM	$4.19
Price to Book MRQ	$2.39
Enterprise to Revenue	2.78
Enterprise to EBITDA	231.96

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	-20.39%
Operating Margin	-31.40%
Return on Assets TTM	-0.07%
Return on Equity TTM	-10.45%

Income Statement

Revenue TTM	$294,620,000
Revenue per Share TTM	$2.29
Quarterly Revenue Growth	34.20%
Gross Profit TTM	$177,612,992
EBITDA	$45,701,000
Net Income to Common TTM	$-60,069,000
Diluted EPS TTM	$-0.50
Quarterly Earnings Growth YoY	34.21%

Balance Sheet

Total Cash MRQ	$661,336,000
Total Cash per Share MRQ	$5.51
Total Debt MRQ	$
Total Debt to Equity MRQ	54.64
Current Ratio MRQ	11.93
Book Value per Share MRQ	$4.29

Cash Flow

Operating Cash Flow TTM	$63,552,000
Levered Free Cash Flow TTM	$33,543,500

DVAX Stock Info as of Jul. 5, 2025

Stock Statistics

Shares Outstanding	125,450,000
Float Shares	101,723,921
Avg 10 Volume	1,944,210
Avg 30 Volume	None
Shares Short	15,169,101
Short Ratio	8.99
Short % of Shares	18.80%
% Held by Insiders	0.59%
% Held by Institutions	108.60%

Stock Price Summary

Beta	1.04
Fifty Two Week Low	$9.22
Fifty Two Week High	$14.63
Fifty Two Week Change	-8.86%
Day 50 MA	$10.19
Day 200 MA	$11.87

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date	2014-11-10